General Actions (Not specific medical benefits for the user)
| Core Action | Mechanism |
| Controls Inflammation | The Inhaled Corticosteroid (ICS) component reduces the swelling and inflammation within the airways, helping to decrease airway hyper-responsiveness over time. |
| Opens Airways (Bronchodilation) | The Long-Acting Beta-Agonist (LABA) component works to relax the muscles around the airways, keeping them open and making breathing easier for an extended period. |
| Prevents Symptoms | Used regularly (maintenance therapy), it helps to reduce the frequency and severity of asthma and COPD symptoms, such as wheezing and shortness of breath. |
| Reduces Exacerbations | The combined effect helps to prevent severe flare-ups or exacerbations of the chronic respiratory condition, improving the patient's overall quality of life. |
⚠️ Important Safety Note:
PulmoCare-L Inhaler is a prescription medication for chronic respiratory conditions.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5